About the OncoPed
More than one year ago, leaders from PierianDx and leading children’s hospitals discussed how to fill a glaring gap in pediatric oncology; there was no clinically-focused pediatric somatic cancer assay on the market. Additionally, many children’s hospitals across the country didn’t have the volume needed to warrant the validation of such specific genomic testing for children.
The result of this feedback was the creation of OncoPed Select, malignancy and research panels specifically tailored to address childhood cancers. The OncoPed assays are the right balance between assay breadth, depth and price.
Contact us today about the OncoPed Select Assay – the right fit for the right cause.